Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
PE dealmaking, exit counts on the rise in Q3: PitchBook
The private equity market is showing signs of recovery, with strong deal activity and lower interest rates driving optimism.
Gabrielle Masson
Oct 20, 2025 5:05pm
French antibody biotech draws in $122M for push to clinic
Oct 16, 2025 11:19am
Fierce Biotech Fundraising Tracker: Peptilogics, Tubulis & more
Oct 16, 2025 11:18am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
Flagship's Lila adds $115M to series A, bringing total to $350M
Oct 14, 2025 11:33am
